Metraipolis › archive › dc_b77ff74c6f8d

BTK Inhibitor Synergizes With CD19-Targeted Chimeric Antigen Receptor-T Cells in Patients With Relapsed or Refractory B-Cell Lymphoma: An Open-Label Pragmatic… — Europe PMC PMID:41123227

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41123227
DOI
10.1002/cam4.71321
License (as archived)
solo-consultazione
Archived
2026-11-09T15:30:27.416Z
SHA-256 of the archived text
f81169dc31bbfb7c98860af2bdc6884213e340c0acdb3a44cb4bf33a39ca2704
Stable URL of this page
https://metraipolis.com/documento/dc_b77ff74c6f8d

How to cite

BTK Inhibitor Synergizes With CD19-Targeted Chimeric Antigen Receptor-T Cells in Patients With Relapsed or Refractory B-Cell Lymphoma: An Open-Label Pragmatic… — Europe PMC PMID:41123227 — Europe PMC (en), https://europepmc.org/article/MED/41123227 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b77ff74c6f8d (Metraipolis archive dc_b77ff74c6f8d, sha256 f81169dc31bbfb7c98860af2bdc6884213e340c0acdb3a44cb4bf33a39ca2704)
BibTeX
@misc{dcb77ff74c6f8d,
  title = {BTK Inhibitor Synergizes With CD19-Targeted Chimeric Antigen Receptor-T Cells in Patients With Relapsed or Refractory B-Cell Lymphoma: An Open-Label Pragmatic… — Europe PMC PMID:41123227},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41123227},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b77ff74c6f8d; sha256 f81169dc31bbfb7c98860af2bdc6884213e340c0acdb3a44cb4bf33a39ca2704},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41123227. Agents can read the archived copy with the MCP tool read_document.